[go: up one dir, main page]

SE8404250D0 - Antigen for tidig graviditetsprovning och kontraceptivt vaccin - Google Patents

Antigen for tidig graviditetsprovning och kontraceptivt vaccin

Info

Publication number
SE8404250D0
SE8404250D0 SE8404250A SE8404250A SE8404250D0 SE 8404250 D0 SE8404250 D0 SE 8404250D0 SE 8404250 A SE8404250 A SE 8404250A SE 8404250 A SE8404250 A SE 8404250A SE 8404250 D0 SE8404250 D0 SE 8404250D0
Authority
SE
Sweden
Prior art keywords
contraceptive
vaccin
pregnancy testing
subunit
antigen
Prior art date
Application number
SE8404250A
Other languages
English (en)
Other versions
SE8404250L (sv
Inventor
O P Bahl
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of SE8404250D0 publication Critical patent/SE8404250D0/sv
Publication of SE8404250L publication Critical patent/SE8404250L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8404250A 1978-02-06 1984-08-27 Antigen for tidig graviditetsprovning och kontraceptivt vaccin SE8404250L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,497 US4234561A (en) 1978-02-06 1978-02-06 Antigen for early pregnancy test and contraceptive vaccine

Publications (2)

Publication Number Publication Date
SE8404250D0 true SE8404250D0 (sv) 1984-08-27
SE8404250L SE8404250L (sv) 1984-08-27

Family

ID=25365917

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7809249A SE7809249L (sv) 1978-02-06 1978-09-01 Antigen for tidig graviditetsprovning och kontraceptivt vaccin
SE8404250A SE8404250L (sv) 1978-02-06 1984-08-27 Antigen for tidig graviditetsprovning och kontraceptivt vaccin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7809249A SE7809249L (sv) 1978-02-06 1978-09-01 Antigen for tidig graviditetsprovning och kontraceptivt vaccin

Country Status (12)

Country Link
US (1) US4234561A (sv)
JP (1) JPS54105224A (sv)
AU (1) AU521868B2 (sv)
BE (1) BE871107A (sv)
CA (1) CA1113389A (sv)
CH (1) CH650593A5 (sv)
DE (1) DE2842612A1 (sv)
FR (1) FR2416014A1 (sv)
GB (3) GB2013690B (sv)
IT (1) IT1101251B (sv)
NL (1) NL7809347A (sv)
SE (2) SE7809249L (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
IL56342A (en) * 1978-12-29 1982-05-31 Zer Tamar Method and means for determining human chorionic gonadotropin in urine
ATE10034T1 (de) * 1979-02-16 1984-11-15 F. Hoffmann-La Roche & Co. Aktiengesellschaft Immunologisches diagnostisches reagenz zur bestimmung der schwangerschaft, verfahren zu dessen herstellung sowie dessen verwendung zur bestimmung der schwangerschaft.
FR2470773B1 (sv) * 1979-11-28 1983-01-28 Pasteur Institut
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
WO1981002522A1 (en) * 1980-03-03 1981-09-17 M Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
US4543339A (en) * 1982-03-16 1985-09-24 Oneill Christopher Early pregnancy detection by detecting enhanced blood platelet activation
US4508643A (en) * 1983-02-08 1985-04-02 Baxter Travenol Laboratories, Inc. Rat antibody to hCG
EP0142387A1 (en) * 1983-08-26 1985-05-22 Anda Biologicals Process for the preparation of vaccines specific for LH and HCG and process for their detection
BE899664A (fr) * 1984-05-15 1984-08-31 Inst Internat De Pathologie Ce Procede de dosage immunologique d'une substance dans un echantillon liquide.
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
US5776093A (en) * 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
FR2702494B1 (fr) * 1993-03-11 1995-06-09 Lafon Labor Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
WO1994020859A1 (fr) * 1993-03-11 1994-09-15 Laboratoire L. Lafon TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
FR2710845B1 (fr) * 1993-10-08 1996-03-29 Lafon Labor Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
GB0002660D0 (en) * 2000-02-04 2000-03-29 Biomade B V Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
IT961450B (it) * 1972-07-17 1973-12-10 Serono Ist Farm Antisiero specifico e metodo per la determinazione radioimmunologica della gonadotropina corionica umana in presenza dell ormone luteinizzante
US3992514A (en) * 1972-07-17 1976-11-16 Istituto Farmacologico Serono S.P.A. Radioimmunoassay method for human chorionic gonadotropin in the presence of luteinizing hormone
CH622426A5 (en) * 1973-05-07 1981-04-15 Univ Ohio Contraceptive composition
US4016250A (en) * 1974-03-22 1977-04-05 Cornell Research Foundation, Inc. Method for testing for pregnancy
JPS5294416A (en) * 1976-01-24 1977-08-09 Paashiyado Taruwaa Gaasaran Vaccine for contraception and use of same

Also Published As

Publication number Publication date
AU521868B2 (en) 1982-05-06
GB2051081A (en) 1981-01-14
NL7809347A (nl) 1979-08-08
SE7809249L (sv) 1979-08-07
GB2051080A (en) 1981-01-14
AU3987978A (en) 1980-03-20
GB2051080B (en) 1983-01-26
GB2013690A (en) 1979-08-15
FR2416014A1 (fr) 1979-08-31
FR2416014B1 (sv) 1983-06-03
IT1101251B (it) 1985-09-28
JPS54105224A (en) 1979-08-18
IT7828492A0 (it) 1978-10-06
GB2051081B (en) 1982-11-24
JPS6340770B2 (sv) 1988-08-12
CH650593A5 (de) 1985-07-31
GB2013690B (en) 1982-11-17
DE2842612A1 (de) 1979-08-09
SE8404250L (sv) 1984-08-27
CA1113389A (en) 1981-12-01
BE871107A (fr) 1979-04-09
US4234561A (en) 1980-11-18

Similar Documents

Publication Publication Date Title
SE8404250L (sv) Antigen for tidig graviditetsprovning och kontraceptivt vaccin
SE8105827L (sv) Immunoanalysprodukter och -metoder
SE8202012L (sv) Humaninterferon-beslektade peptider, antigener, antikroppar och forfarande for framstellning derav
BR8807567A (pt) Teste imuno-enzimatico simultaneo para a deteccao de antigeno e/ou anticorpo em humanos
DE3779909D1 (de) In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
SE7904386L (sv) Biologisk provmetod med utnyttjande av fast fas
ES2096588T3 (es) Anticuerpos monoclonales para inducir tolerancia.
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
AR033832A1 (es) Un metodo ex vivo para diagnosticar una enfermedad autoinmune, anticuerpo, composicion de diagnostico que lo comprende, y usos del anticuerpo
ATE43968T1 (de) Hapten- und muramylpeptidkonjugate, mit immunogenischer wirksamkeit und die selben enthaltende zubereitungen.
DE2964944D1 (en) A serological method for determining the presence of neisseria gonorrhoeae antibodies in human serum, a species-specific heat stable antigen to be used in this method and a method for the preparation of that antigen
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
ATE196767T1 (de) Neue cocain-derivate und protein- und polypeptid- cocain-derivate, konjugate und markierte verbindungen
Tjokronegoro et al. Degradation of immunoglobulins by secretions of human reproductive tracts
Sun et al. The sites of antigen formation in different developmental stages of Clonorchis sinensis
GB2004744A (en) Immunological preparations containing major histocompatibility complex antigen
Petrunin et al. Immunochemical identification of organ-specific human placental α in2-globulin and its content in the amniotic fluid
Tatarinov et al. Comparative immunochemical analysis of specific β-globulins of the “pregnancy zone” in humans and other mammals
ATE175357T1 (de) Empfängnisverhütender impfstoff
Silberberg et al. Studies of the antigenicity of human malignant melanoma for rabbits. Findings in blood serum of antibody response of rabbits following immunization procedures with extracts from malignant melanomas and control materials
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
Menzoian The apparent immunological tolerance of the female rabbit to homologous seminal plasma proteins
Scheiffarth et al. Determination of the blood proteins in rats and rabbits with paper electrophoresis. II. Effect of the mode of sensitization on the behavior of the blood protein bodies in case of the same antigen
NO952506L (no) Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8404250-6

Effective date: 19890517

Format of ref document f/p: F